UA48440A - Способ лечения дисбиозов кишечника - Google Patents
Способ лечения дисбиозов кишечника Download PDFInfo
- Publication number
- UA48440A UA48440A UA2001075364A UA200175364A UA48440A UA 48440 A UA48440 A UA 48440A UA 2001075364 A UA2001075364 A UA 2001075364A UA 200175364 A UA200175364 A UA 200175364A UA 48440 A UA48440 A UA 48440A
- Authority
- UA
- Ukraine
- Prior art keywords
- cfu
- probiotic
- symbiter
- intestinal
- treatment
- Prior art date
Links
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 25
- 208000027244 Dysbiosis Diseases 0.000 title claims abstract description 24
- 230000007140 dysbiosis Effects 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000006041 probiotic Substances 0.000 claims abstract description 24
- 230000000529 probiotic effect Effects 0.000 claims abstract description 24
- 235000018291 probiotics Nutrition 0.000 claims abstract description 24
- 241000186660 Lactobacillus Species 0.000 claims abstract description 13
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000725 suspension Substances 0.000 claims abstract description 5
- 235000019260 propionic acid Nutrition 0.000 claims abstract description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims abstract 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000012876 topography Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 3
- 210000000664 rectum Anatomy 0.000 abstract 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 13
- 230000002906 microbiologic effect Effects 0.000 description 12
- 210000000936 intestine Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 7
- 210000003608 fece Anatomy 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 6
- 244000005706 microflora Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 230000013872 defecation Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UUKPIWYXWLJPJF-UHFFFAOYSA-N 2-(2-adamantyl)-1-(4-iodophenyl)guanidine Chemical compound C1C2CC(C3)CC1CC3C2N=C(N)NC1=CC=C(I)C=C1 UUKPIWYXWLJPJF-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 206010017367 Frequent bowel movements Diseases 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 208000036654 deficiency anemia Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229940095399 enema Drugs 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010049140 Pharyngotonsillitis Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000004607 Tracheobronchomalacia Diseases 0.000 description 1
- 208000017291 Williams-Campbell syndrome Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Способ лечения дисбиозов кишечника предусматривает применение бактериальной суспензии. Пробиотик "Симбитер", представляющий собой многокомпонентную ассоциацию бифидобактерий, лактобацилл, лактококков и пропионовокислых бактерий, назначают больным перорально и одновременно ректально.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2001075364A UA48440A (ru) | 2001-07-26 | 2001-07-26 | Способ лечения дисбиозов кишечника |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2001075364A UA48440A (ru) | 2001-07-26 | 2001-07-26 | Способ лечения дисбиозов кишечника |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA48440A true UA48440A (ru) | 2002-08-15 |
Family
ID=74216115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001075364A UA48440A (ru) | 2001-07-26 | 2001-07-26 | Способ лечения дисбиозов кишечника |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA48440A (ru) |
-
2001
- 2001-07-26 UA UA2001075364A patent/UA48440A/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2897948T3 (es) | Composiciones de cannabidiol y usos de las mismas | |
| US4314995A (en) | Pharmaceutical lactobacillus preparations | |
| US20200376047A1 (en) | Methods for the treatment of inflammation and inflammatory conditions | |
| RU2297835C1 (ru) | Препарат для лечения неинфекционных воспалительных болезней кишечника | |
| RU2400235C1 (ru) | Способ лечения больных с дисбактериозом кишечника | |
| UA48440A (ru) | Способ лечения дисбиозов кишечника | |
| RU2461387C2 (ru) | Способ лечения диспепсии у телят | |
| RU2367454C1 (ru) | Средство интимной гигиены "фемивит" | |
| RU2614730C1 (ru) | Антибактериальное средство и способ лечения кишечного иерсиниоза, или псевдотуберкулеза, или эшерихиоза | |
| Buckle et al. | Painful dysphagia due to monilial oesophagitis | |
| UA140260U (uk) | Спосіб корекції ендотоксикозу у хворих на гострі кишкові інфекції змішаної вірусно-бактеріальної етіології | |
| RU2817214C1 (ru) | Способ профилактики послеоперационных инфекционных осложнений у нейрохирургических пациентов в хроническом критическом состоянии, обусловленном повреждением головного мозга | |
| RU2817214C9 (ru) | Способ профилактики послеоперационных инфекционных осложнений у нейрохирургических пациентов в хроническом критическом состоянии, обусловленном повреждением головного мозга | |
| RU2805329C2 (ru) | Комбинированный биологический препарат для лечения эндометритов у сельскохозяйственных животных | |
| Croydon | Clinical experience of amoxycillin in the United Kingdom | |
| RU2203076C1 (ru) | Способ лечения и профилактики желудочно-кишечных болезней телят | |
| RU2341269C1 (ru) | Способ лечения хирургического эндотоксикоза | |
| RU2185841C2 (ru) | Способ лечения хронических фарингитов на фоне дисбактериоза кишечника | |
| Brightman | Tetanus: an ever‐present infection risk | |
| Dawson et al. | The Effect of Human Saliva on the Cholera Vibrio in Vitro: a Pilot Study | |
| RU2293567C2 (ru) | Способ лечения дисбактериоза кишечника | |
| RU2191551C1 (ru) | Способ лечения неосложненных фронтитов | |
| RU2178300C1 (ru) | Способ лечения больных полипозом толстого кишечника | |
| RU1803116C (ru) | Способ лечени острых кишечных инфекций у детей, вызванных условно-патогенной флорой | |
| RU2283120C1 (ru) | Способ лечения дисбактериоза кишечника при перитоните |